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We examined whether pretreatment with a small dose of
thiopental was effective in reducing pain induced by the
intravenous injection of rocuronium. Withdrawal movement
was used to assess pain reduction. Ninety patients were
randomly assigned to one of two groups: patients in the control
group were pretreated with 2 mL saline, and those in the
thiopental group were pretreated with 2mL (50 mg) thiopental.
Thiopental 5 mg/kg was injected intravenously. After a loss of
consciousness, the upper arm was compressed with a rubber
tourniquet, and the pretreatment drugs were administered.
Thirty seconds later the tourniquet was removed and 0.6 mg/kg
rocuronium was administered. Withdrawal movement was
assessed using a four-grade scale: no movement, movement
limited to the wrist, to the elbow or to the shoulder. The fre-
quency of withdrawal movement in the group pretreated with
thiopental was lower than in the control group (34 vs. 13, p
< 0.05). We concluded that pretreatment with 2 mL (50 mg)
thiopental is effective in reducing pain caused by the intrave-
nous injection of rocuronium.
Key Words: Pain, rocuronium, thiopental
INTRODUCTION
Rocuronium, a derivative of aminosteroid, is a
non-depolarizing muscle relaxant with a rapid
onset time and has a similar structure to vecuro-
nium.
1,2 While rocuronium is a useful during
endotracheal intubation, it induces pain during
intravenous (IV) injection. If injected intrave-
nously prior to the loss of consciousness, hot and
burning sensations develop, and even if injected
after the loss of consciousness by induction
agents, a severe withdrawal movement, such as
withdrawing the injected hand or arm, may occur
due to pain.
3-5 Various studies have attempted to
reduce this pain.
Previous studies have shown a reduction in
pain to some degree with pretreatment using lido-
caine,
6 fentanyl,
7 or an injection of a mixture of
rocuronium and sodium bicarbonate.
8,9 Although
the pathophysiological mechanism of the pain
caused by the IV administration of rocuronium is
not clear, it has been reported that the pain may
be due to the activation of nociceptors by the
osmolality or pH of the solution, or activation by
the release of endogenous mediators, such as
histamine, kinin, and other substances mediating
inflammation.
4,10
The aim of this study was to evaluate the effects
of pretreatment with a small dose of thiopental on
pain associated with the IV administration of
rocuronium by assessing withdrawal movement.
MATERIALS AND METHODS
This study was performed after obtaining
approval from the Ethics Committee at our
hospital. The purpose and methods of the study
were explained to the patients prior to the experi-
ment and consent was obtained from each patient.
This study was performed on 90 patients who
were scheduled for elective surgery, who were
ASA class I-II, and were between 16 to 69 years
old. Patients who had a specific response to
thiopental in their medical history, who had a
respiratory disease such as asthma or chronic ob-
structive pulmonary disease, who were pregnant
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women, or who were being treated with analgesic
drugs on the day of surgery were excluded from
this study. In all patients, an 18-gauge catheter
was inserted into a vein on the dorsum of the
hand, and an IV infusion of lactated Ringer's
solution was started. The patients were premedi-
cated with glycopyrrolate and midazolam 30
minutes before the induction of anesthesia. All
patients were monitored with an automatic nonin-
vasive blood pressure measurement, an electro-
cardiogram, and pulse oximetry.
Patients were randomly divided to one of two
groups: the control group (n = 45) pretreated with
2 mL of saline and the thiopental group (n = 45)
pretreated with 2 mL (50 mg) of thiopental. After
confirming that the IV infusion could be injected
without resistance, anesthesia was induced with
2.5% thiopental 5 mg/kg. Just after the loss of con-
sciousness, the route of the IV infusion was
occluded by applying a rubber tourniquet at the
middle of the forearm. If venous occlusion by the
rubber tourniquet was not sufficient, manual
compression was also applied. Pretreatment drugs
were administered and the tourniquet was
released after 30 seconds; IV infusion was applied
sufficiently to ensure the removal of residual ef-
fects. Then, an intubated dose of 0.6 mg/kg rocu-
ronium was injected intravenously for 5 seconds.
The degree of the movement of the patients
during the injection was divided into four grades
and withdrawal movement was assessed and
scored as follows: no movement = 0, movement
limited to the hand = 1, movement limited to the
forearm including the elbow joint = 2, and move-
ment of the upper arm including the shoulder
joint = 3.
11
Age and weight were compared using the
unpaired t-test and gender was compared using
the Chi-square test. The risk degree for with-
drawal movement was compared using the odds
ratio and 95% confidence interval (CI), and with-
drawal movements were compared using Fisher's
exact test. A p value of less than 0.05 was con-
sidered significant.
RESULTS
The demographic characteristics (age, sex, and
weight) were not significantly different between
the groups (Table 1). Thirty-four of 45 patients
(76%) in the control group and 13 of 45 patients
(29%) in the thiopental pretreatment group
showed withdrawal movement, which indicates
that the odds ratio of withdrawal movement in
the thiopental pretreatment group was signifi-
cantly lower than the control group (Odds ratio:
0.131, 95% CI: 0.052-0.335). A comparison of the
degree of withdrawal movement showed that the
frequency of the each movement of hand, fore-
arm, and upper arm in the thiopental pretreated
group was significantly lower than in the control
group: 11 vs. 18 (24.5% vs. 40%), 2 vs. 9 (4% vs.
20%), and 0 vs. 7 (0% vs. 16%), respectively (p<
0.05, Table 2). Within 24 hours after surgery, side
effects such as pain, edema, and wheals in the
injection area were not detected in any patients.
DISCUSSION
When rocuronium is injected intravenously, it
causes pain in approximately 50-80% of patients,
3,4
and in unconscious patients, IV injection causes
withdrawal movement of the hand, the arm, or
the shoulder. Such withdrawal movement may
induce pulmonary aspiration in children,
12 cause
dislocation or displacement of the IV catheter
resulting in difficulty in administrating additional
drugs, and induce an emergency situation.
Table 1. Demographic Data
Control group (n = 45) Thiopental group (n = 45)
Sex (M/F) 25/20 17/28
Age (yrs) 41 ± 15 43 ± 15
Weight (kg) 61.2 ± 9.4 61.3 ± 9.1
Values are number of patients or mean ± SD. There were no significant differences between groups.Thiopental and Rocuronium Injection Pain
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The mechanism by which rocuronium causes
pain has not yet been characterized, however, the
pain is known to be induced by a low pH
13 or by
the release of local mediators such as brady-
kinin.
4,10 Klement and Arndt 13 reported that IV
injections with a pH lower than 4 induce pain,
and the lower the pH, the more severe the pain.
Rocuronium is a pH 4 isotonic solution
4 and the
pain induced by IV injection of this drug has been
reduced by injecting of a mix of NaHCO3 and
rocuronium. Several studies have reported that
the cause of pain induced by IV injections may be
a low pH.
8,9 In this study, we initially wanted to
compare the effects of an IV injection of a mixture
of thiopental and rocuronium (thus neutralizing
the acidity) to pretreatment with thiopental on the
frequency and severity of pain caused by the IV
injection of rocuronium. However, because a
mixture of the two drugs forms white precipitates,
a study evaluating the mixture of thiopental and
rocuronium could not be performed. In the study
we conducted examining pretreatment with thio-
pental, of the 45 control patients pretreated with
normal saline prior to the administration of the
intubated dose of rocuronium, 16 patients (35.6%)
showed severe withdrawal movement including
the upper arm or shoulder. However in the 45
experimental patients pretreated with 2 mL (50
mg) thiopental, only 2 patients (4.4%) showed
severe withdrawal movement (p<0.05). These
results show that pretreatment with thiopental
reduces pain induced by the IV injection of ro-
curonium.
Although the mechanism by which pretreat-
ment with thiopental reduces the pain induced by
the IV injection of rocuronium is unknown, it can
be speculated that the following mechanisms,
alone or in combination, are involved. First, the
induction dose of thiopental 5 mg/kg may blunt
the cognition of pain. However, because the same
dose of thiopental was administered to the control
group, it is believed that thiopental did not have
a significant effect on the results. Although the
dose of thiopental administered for pretreatment
was small (50 mg), its effect on the frequency and
severity of the pain cannot be ruled out. Second,
when thiopental is administered as a pretreatment
drug it may suppress the local cognition of pain
through nociceptors present in the peripheral
veins.
14-16 Third, the characteristics of pain from
the IV injection of rocuronium appear immedi-
ately after the injection and severity decreases
with repeated administration, which is similar to
the characteristics of pain induced by IV injection
of propofol; thus, mediators similar to those
involved in the kininogen cascade related to pain
induced by IV propofol injections may be in-
volved with the pain associated with rocuronium
injections.
4,10 Further, thiopental may block the
release of mediators such as bradykinin.
16,17
Finally, concentrations of thiopental remaining on
the walls of blood vessels may neutralize rocuro-
nium and thus reduce the pain induced by IV
injection.
In conclusion, pretreatment with 2 mL (50 mg)
thiopental is considered to be effective in reducing
pain induced by the IV injection of rocuronium.
REFERENCES
1. Mayer M, Doenicke A, Hofmann A, Peter K. Onset and
recovery of rocuronium (Org 9426) and vecuronium
under enflurane anaesthesia. Br J Anaesth 1992;69:511-
2.
2. Bartkowski RR, Witkowski TA, Azad S, Lessin J, Marr
A. Rocuronium onset of action: a comparison with






Grading of withdrawal movement
Wrist Elbow Shoulder
Control 11 (24.4%) 34 (75.6%) 18 (40.0%) 9 (20.0%) 7 (15.6%)
Thiopental 32 (71.1%)* 13 (28.9%)* 11 (24.5%)* 2 (4.4%)* 0 (0%)*
Values are numbers of patients.
*p<0.05 compared with the control group.Jong-Taek Park, et al.
Yonsei Med J Vol. 46, No. 6, 2005
atracurium and vecuronium. Anesth Analg 1993;77:574-
8.
3. Steegers MA, Robertson EN. Pain on injection of
rocuronium bromide. Anesth Analg 1996;83:203.
4. Borgeat A, Kwiatkowski D. Spontaneous movements
associated with rocuronium: is pain on injection the
cause? Br J Anaesth 1997;79:382-3.
5. Moorthy SS, Dierdorf SF. Pain on injection of rocuro-
nium bromide. Anesth Analg 1995;80:1067.
6. Cheong KF, Wong WH. Pain on injection of rocuro-
nium: influence of two doses of lidocaine pretreatment.
Br J Anaesth 2000;84:106-7.
7. Borgeat A, Kwiatkowski D, Ruetsch YA. Spontaneous
movements associated with rocuronium injection: the
effects of prior administration of fentanyl. J Clin Anesth
1997;9:650-2.
8. Chiarella AB, Jolly DT, Huston CM, Clanachan AS.
Comparison of four strategies to reduce the pain
associated with intravenous administration of rocuro-
nium. Br J Anaesth 2003;90:377-9.
9. Turan A, Memis D, Karamanlioglu B, Sut N, Pamukcu
Z. The prevention of pain from injection of rocuronium
by magnesium sulphate, lignocaine, sodium bicarbo-
nate and alfentanil. Anaesth Intensive Care 2003;31:
277-81.
10. Blunk JA, Seifert F, Schmelz M, Reeh PW, Koppert W.
Injection pain of rocuronium and vecuronium is
evoked by direct activation of nociceptive nerve
endings. Eur J Anaesthesiol 2003;20:245-53.
11. Mencke T, Beerhalter U, Fuchs-Buder T. Spontaneous
movements, local reactions and pain on injection of
rocuronium. A comparison between female and male
patients. Acta Anaesthesiol Scand 2001;45:1002-5.
12. Lui JT, Huang SJ, Yang CY, Hsu JC, Lui PW.
Rocuronium-induced generalized spontaneous move-
ments cause pulmonary aspiration. Chang Gung Med
J 2002;25:617-20.
13. Klement W, Arndt JO. Pain on intravenous injection of
some anesthetic agents is evoked by the unphysioligical
osmolality or pH of their formulations. Br J Anaesth
1991;66:189-95.
14. Arndt JO, Klement W. Pain evoked by polymodal
stimulation of hand veins in humans. J Physiol 1991;
440:467-78.
15. Anker-Moller E, Spangsberg N, Arendt-Nielsen L,
Schultz P, Kristensen MS, Bjerring P. Subhypnotic
doses of thiopentone and propofol cause analgesia to
experimentally induced acute pain. Br J Anaesth 1991;
66:185-8.
16. Agarwal A, Ansari MF, Gupta D, Pandey R, Raza M,
Singh PK, et al. Pretreatment with thiopental for
prevention of pain associated with propofol injection.
Anesth Analg 2004;98:683-6.
17. Scott RP, Saunders DA, Norman J. Propofol: clinical
strategies for preventing the pain of injection. Anaes-
thesia 1988;43:492-4.